Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Alcohol Drinking 5 Prostatic Neoplasms 2 Head and Neck Neoplasms 2 Substance-Related Disorders 1 Social Isolation 1 Smoking Cessation 1 Risk-Taking 1 Pancreatic Cyst 1 Pain 1 Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Flushing 1 Fanconi Anemia 1 Esophageal Neoplasms 1 Driving Under the Influence 1 Depression 1 Colorectal Neoplasms 1 Carney Complex 1 Cardiovascular Diseases 1 Binge-Eating Disorder 1 Binge Drinking 1 Alzheimer Disease 1 Agnosia 1

Interventions

Bevacizumab 119 Fluorouracil 91 Leucovorin 83 Cetuximab 83 Oxaliplatin 80 pembrolizumab 70 Irinotecan 67 Nivolumab 46 Capecitabine 43 Specimen Handling 40 regorafenib 30 Folfox protocol 29 trifluridine tipiracil drug combination 28 Magnetic Resonance Spectroscopy 27 Biopsy 27 Panitumumab 26 Standard of Care 25 HMPL-013 25 IFL protocol 21 Gemcitabine 20 Blood Specimen Collection 19 atezolizumab 18 Trifluridine 18 Cisplatin 18 tislelizumab 17 balstilimab 16 Colonoscopy 16 Carboplatin 16 encorafenib 15 Paclitaxel 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Neoplasms × Ethanol × 1 year × Clear all

NCT03955510 2025-10-28

AFT

Rush University Medical Center

Phase NA Active not recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡